Signaling Pathways
- A8441 GSK4613643 CitationTarget: PLKSummary: Plk1 inhibitor
- A8487 Nocodazole1 CitationTarget: Microtubules/TubulinsSummary: Tubulin production inhibitor,anti-neoplastic agent
- A8625 CP-466722Target: ATMSummary: ATM inhibitor,potent and reversible
- A8629 DBeQTarget: P97 ATPaseSummary: P97 ATPase inhibitor
- A8650 SaxagliptinTarget: DPP-4Summary: Selective DPP4 inhibitor
- B1585 SC-514Summary: ATP-competitive IKK-2 inhibitor, orally active
- B3252 Dorsomorphin (Compound C)5 CitationTarget: AMPKSummary: AMPK inhibitor
- B5780 UAMC 00039 dihydrochlorideTarget: Dipeptidyl-peptidase IISummary: dipeptidyl peptidase II (DPP-II) inhibitor
- A8885 Ro 33064 CitationTarget: Cyclin-Dependent KinasesSummary: An ATP-competitive, potent CDK1 inhibitor
- B5881 RI-2Target: RAD51Summary: Optimized reversible RAD51 inhibitor